Drug Shortage Report for COLISTIMETHATE FOR INJECTION
| Report ID | 149600 |
| Drug Identification Number | 02403544 |
| Brand name | COLISTIMETHATE FOR INJECTION |
| Common or Proper name | Colistimethate for Injection 150 mg SD Vial 6.5 mL |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | COLISTIN |
| Strength(s) | 150MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 6.5 mL |
| ATC code | J01XB |
| ATC description | OTHER ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-12-14 |
| Actual start date | |
| Estimated end date | 2022-02-21 |
| Actual end date | 2022-02-22 |
| Shortage status | Resolved |
| Updated date | 2022-04-13 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to further production delays we will be extending the backorder on our Colistimethate for Injection 150 mg SD Vial 6.5 mL until February 21, 2022. Sterimax is an alternate supplier of Colistimethate for Injection and have been informed of our impending supply interruption. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2022-04-13 | French | Compare |
| v6 | 2022-04-13 | English | Compare |
| v5 | 2021-12-15 | English | Compare |
| v4 | 2021-12-13 | French | Compare |
| v3 | 2021-12-13 | English | Compare |
| v2 | 2021-11-18 | French | Compare |
| v1 | 2021-11-18 | English | Compare |
Showing 1 to 7 of 7